Gene · 2046
Papers2,828
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,828
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the Antitumor Mechanisms of Bai-Hua-She-She-Cao and Ban-Zhi-Lian against Head and Neck Squamous Cell Carcinoma: A Study on Natural Anticancer Therapeutics. | ACS Omega | 2025 | 40821538 | PubTator, text mining | PubMed |
| Analysis of the immune microenvironment in colorectal cancer with different KRAS gene subtypes. | BMC Cancer | 2025 | 40759935 | PubTator, text mining | PubMed |
| Prime assembly with linear DNA donors enables large genomic insertions. | bioRxiv | 2025 | 40667017 | PubTator, text mining | PubMed |
| Ephrin-A5 or EphA7 stimulation is anti-proliferative for human rhabdomyosarcoma in vitro. | Skelet Muscle | 2025 | 40426233 | PubTator, text mining | PubMed |
| Restoration of pp60Src Re-Establishes Electron Transport Chain Complex I Activity in Pulmonary Hypertensive Endothelial Cells. | Int J Mol Sci | 2025 | 40332450 | PubTator, text mining | PubMed |
| Rewriting regulatory DNA to dissect and reprogram gene expression. | Cell | 2025 | 40245860 | PubTator, text mining | PubMed |
| Association of heightened host and tumor immunity with prolonged duration of response to checkpoint inhibition across solid tumors. | Sci Rep | 2025 | 40240402 | PubTator, text mining | PubMed |
| TopEC: prediction of Enzyme Commission classes by 3D graph neural networks and localized 3D protein descriptor. | Nat Commun | 2025 | 40108108 | PubTator, text mining | PubMed |
| Mismatch prime editing gRNA increased efficiency and reduced indels. | Nat Commun | 2025 | 39747083 | PubTator, text mining | PubMed |
| Kinomic profiling to predict sunitinib response of patients with metastasized clear cell Renal Cell Carcinoma. | Neoplasia | 2025 | 39724752 | PubTator, text mining | PubMed |
| The neuroprotective effect of 1,25-dyhydroxyvitamin D3 (calcitriol) and probiotics on the rotenone-induced neurotoxicity model in SH-SY5Y cells. | Drug Chem Toxicol | 2025 | 39582340 | PubTator, text mining | PubMed |
| A benchmarked, high-efficiency prime editing platform for multiplexed dropout screening. | Nat Methods | 2025 | 39562753 | PubTator, text mining | PubMed |
| Anti-Resistant Strategies: Icotinib Derivatives as Promising Non-Small Cell Lung Cancer Therapeutics. | Curr Cancer Drug Targets | 2025 | 38967075 | PubTator, text mining | PubMed |
| Ephrin-A5 or EphA7 stimulation is anti-proliferative for human rhabdomyosarcoma in vitro. | bioRxiv | 2024 | 39763772 | PubTator, text mining | PubMed |
| Effect of body mass index on semen quality, sperm chromatin integrity and sperm DNA methylation. | Obes Res Clin Pract | 2024 | 39358131 | PubTator, text mining | PubMed |
| Regulation of protein phosphorylation by PTPN2 and its small-molecule inhibitors/degraders as a potential disease treatment strategy. | Eur J Med Chem | 2024 | 39178726 | PubTator, text mining | PubMed |
| A pan-cancer analysis of EphA family gene expression and its association with prognosis, tumor microenvironment, and therapeutic targets. | Front Oncol | 2024 | 38952552 | PubTator, text mining | PubMed |
| PKC-α is involved in the signaling of phagocytosis induced by two snake venom secretory PLA2S in macrophages. | Toxicon | 2024 | 38908525 | PubTator, text mining | PubMed |
| A benchmarked, high-efficiency prime editing platform for multiplexed dropout screening. | bioRxiv | 2024 | 38585933 | PubTator, text mining | PubMed |
| Evaluation of novel synthesized thiazole derivatives as potential aromatase inhibitors against breast cancer. | Future Med Chem | 2024 | 38488019 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2046/papers?page=2